2011
DOI: 10.5138/ijdd.2010.0975.0215.03052
|View full text |Cite
|
Sign up to set email alerts
|

Chitosan Microspheres as Potential Vaccine Delivery Systems.

Abstract: The recent advances in controlled delivery systems for protein pharmaceuticals such as microspheres, liposomes, pumps and implants, have provided a new avenue for delivery of vaccine antigens. Adjuvants aimed at increasing the immunogenicity of recombinant antigens remain a focus in vaccine development worldwide, there is currently considerable care for the development of chitosan microspheres as controlled release of vaccines, since the major disadvantage of several currently available vaccines is the need fo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 43 publications
(39 reference statements)
0
2
0
Order By: Relevance
“…Micro- and nanoparticles of chitosan and its derivatives are the most preferable form of vaccine adjuvants and delivery vehicles [71,72,73]. Microspheres obtained from chitosan are more effective adjuvants for different antigens compared with commonly used microspheres from polylactic acid (PLA) and poly(lactic-co-glycolic) acid (PLGA), since chitosan microspheres provide a controlled release rate of captured antigens [71]. As a result, the need for repeated administrations, which is the main drawback of some currently available vaccines, is eliminated.…”
Section: Adjuvant Familiesmentioning
confidence: 99%
“…Micro- and nanoparticles of chitosan and its derivatives are the most preferable form of vaccine adjuvants and delivery vehicles [71,72,73]. Microspheres obtained from chitosan are more effective adjuvants for different antigens compared with commonly used microspheres from polylactic acid (PLA) and poly(lactic-co-glycolic) acid (PLGA), since chitosan microspheres provide a controlled release rate of captured antigens [71]. As a result, the need for repeated administrations, which is the main drawback of some currently available vaccines, is eliminated.…”
Section: Adjuvant Familiesmentioning
confidence: 99%
“…Chitosan can be used to prepare microspheres of different sizes. The combination of microspheres and drugs can avoid the use of organic solvents and prevent the denaturation of antigenic proteins (15). Chitosan has a unique polycationic property.…”
Section: Introductionmentioning
confidence: 99%